Opinion

Video

Economic Impact of IPF

Author(s):

Justin Oldham, MD, MS

The panel explores how IPF affects patient productivity and its contribution to the disease's overall economic burden.

Current Time 0:00
Duration 1:31
Loaded: 10.73%
Stream Type LIVE
Remaining Time 1:31
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Video content above is prompted by the following:

    1. What is the impact of IPF on patient productivity and how does this contribute to the overall economic burden of the disease? 
    Related Videos
    Dr Geoffrey Rutledge
    Telehealth's Journey from Limited Use to a Health Care Essential
    3 experts are featured in this series.
    Managing Complexity: Standardizing Workflows for Multiple Bispecific Therapies
    CGM Coverage and Access
    CGM Coverage and Access
    5 experts are featured in this series
    Minimizing Antibiotic Resistance Development in Uncomplicated UTIs
    4 experts are featured in this series.
    Expanding Access to Alzheimer Disease Care: Leveraging Referral Networks and Telemedicine for Patients in Underserved Areas
    4 experts are featured in this series.
    From Time Constraints to Reimbursement: Addressing Key Hurdles in Cognitive Screening for Alzheimer Disease
    5 experts are featured in this series
    Patient Burden Associated With Uncomplicated UTIs
    Health Care System Integration
    Health Care System Integration
    1 expert is featured in this series.
    Tailoring HS Treatment: The Path to Better Patient Outcomes
    3 experts are featured in this series.
    Partnerships in Bispecific Therapy: A Model for Supporting Community Oncology
    Related Content
    Clinician documentation | Image Credit: - DC Studio - stock.adobe.com
    March 26th 2025

    Speech Recognition Tools May Boost Clinician Documentation Efficiency

    Brooke McCormick
    Documentation efficiency was higher among younger and male clinicians.
    managed care cast logo
    December 23rd 2024

    Five Years Later: Ongoing COVID-19 Challenges, Next Steps

    Brooke McCormick
    On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
    FDA Approved. | Image Credit: wladimir1804 - stock.adobe.com
    March 26th 2025

    FDA Approves Cabozantinib for Advanced Pancreatic Neuroendocrine Tumors

    Giuliana Grossi
    With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer Network guidelines, this approval reinforces cabozantinib’s role in improving outcomes for patients facing these challenging cancers.
    Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
    December 17th 2024

    Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

    Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.
    FDA approval graphic | Image Credit: wladimir1804 - stock.adobe.com
    March 25th 2025

    FDA Approves First New Class of Oral Antibiotics for Uncomplicated UTIs in Nearly 30 Years

    Brooke McCormick
    The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract infections (UTIs) in nearly 30 years.
    Woman affected by blurry vision | Image Credit: Prostock-studio - stock.adobe.com
    March 25th 2025

    Ocular Adverse Events From Mirvetuximab Soravtansine Not Associated With HRQoL Impact in FRα+ Ovarian Cancer

    Brooke McCormick
    New phase 3 data provide reassurance on safety, tolerability, and overall benefit-risk of mirvetuximab soravtansine (Elahere) for patients with folate receptor alpha-positive (FRα+), platinum-resistant ovarian cancer.

    2 Commerce Drive
    Suite 100
    Cranbury, NJ 08512

    © 2025 MJH Life Sciences® and AJMC®.
    All rights reserved.

    About
    Contact
    Editorial Boards
    Advertise
    Do Not Sell My Information
    Terms & Conditions
    Privacy Policy
    AJMC Managed Markets Network Logo
    CH LogoCenter for Biosimilars Logo